To understand how ILC2-deficiency may shape the anti-tumoral microenvironment, intestinal tumor epithelial cells (CD45-EpCAM+) and total immune cells (CD45+) were sorted from ILC2-deficient and Cre-control mice, and 10x genomics single-cell RNA sequencing (scRNAseq) was performed. The gene discussed is EPCAM; the disease is neoplasm.